In this subtitle the following words have the meanings indicated. “Authorized prescriber” means a licensed physician, licensed podiatrist, certified midwife licensed under Title 8, Subtitle 6D of this article, or certified advanced practice nurse with prescriptive authority under § 8–508 of this article. “Group model health maintenance organization” has the meaning stated in § 19–713.6 of the Health – General Article. “Health maintenance organization” has the meaning stated in § 19–701(g) of the Health – General Article. “Institutional facility” means a facility other than a nursing home whose primary purpose is to provide a physical environment for patients to obtain inpatient or emergency care. “Institutional facility” does not include an urgent care facility that is not part of a facility. “Prescriber–pharmacist agreement” means an agreement between an authorized prescriber and a licensed pharmacist that is disease–state specific and specifies the protocols that may be used. “Protocol” means a course of treatment predetermined by the authorized prescriber and licensed pharmacist according to generally accepted medical practice for the proper completion of a particular therapeutic or diagnostic intervention. “Therapy management contract” means a voluntary arrangement that is: Disease–state specific; Agreed on by: One licensed pharmacist and the licensed pharmacist’s designated alternate licensed pharmacists; One authorized prescriber and alternate designated authorized prescribers involved directly in patient care; and One patient receiving care from an authorized prescriber and a licensed pharmacist pursuant to a prescriber–pharmacist agreement and protocol under this subtitle; and Related to treatment using drug therapy, laboratory tests, or medical devices, under defined conditions or limitations for the purpose of improving patient outcomes.